Home
>
National Drug Code (NDC)
>
Neostigmine Methylsulfate
Neostigmine Methylsulfate - 63323-382-10 - (NEOSTIGMINE METHYLSULFATE)
Drug Information of Neostigmine Methylsulfate
| Product NDC: | 63323-382 |
| Proprietary Name: | Neostigmine Methylsulfate |
| Non Proprietary Name: | NEOSTIGMINE METHYLSULFATE |
| Active Ingredient(s): | 5 mg/mL & nbsp; NEOSTIGMINE METHYLSULFATE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Neostigmine Methylsulfate
| Product NDC: | 63323-382 |
| Labeler Name: | Fresenius Kabi USA, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20001018 |
Package Information of Neostigmine Methylsulfate
| Package NDC: | 63323-382-10 |
| Package Description: | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-382-10) > 10 mL in 1 VIAL, MULTI-DOSE |
NDC Information of Neostigmine Methylsulfate
| NDC Code | 63323-382-10 |
| Proprietary Name | Neostigmine Methylsulfate |
| Package Description | 10 VIAL, MULTI-DOSE in 1 TRAY (63323-382-10) > 10 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 63323-382 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | NEOSTIGMINE METHYLSULFATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20001018 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | NEOSTIGMINE METHYLSULFATE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |
